MyFinsight
Home
Blog
About
Cash and cash
equivalents
$73,849K
(184.06%↑ Y/Y)
Prepaid expenses and
other current assets
$6,791K
(130.36%↑ Y/Y)
Short-term investments
$21K
(-99.98%↓ Y/Y)
Total current assets
$80,661K
(-44.28%↓ Y/Y)
Operating lease
right-of-use asset
$626K
(19.92%↑ Y/Y)
Other assets
$173K
(-92.08%↓ Y/Y)
Total assets
$81,460K
(-44.76%↓ Y/Y)
Total liabilities and
stockholders' equity
$81,460K
(-44.76%↓ Y/Y)
Total stockholders'
equity
$74,797K
(-45.37%↓ Y/Y)
Total liabilities
$6,663K
(-36.84%↓ Y/Y)
Accumulated deficit
-$151,893K
(-85.23%↓ Y/Y)
Additional paid-in capital
$226,690K
(3.54%↑ Y/Y)
Total current
liabilities
$6,387K
(-38.05%↓ Y/Y)
Operating lease
liability, net of current...
$276K
(21.05%↑ Y/Y)
Accrued liabilities
$3,900K
(-19.37%↓ Y/Y)
Accounts payable
$2,086K
(-58.74%↓ Y/Y)
Operating lease
liability, current portion
$401K
(-3.84%↓ Y/Y)
Back
Back
Balance Sheet
Aardvark Therapeutics, Inc. (AARD)
Aardvark Therapeutics, Inc. (AARD)
source: myfinsight.com